MASS icon

908 Devices

6.81 USD
-0.14
2.01%
At close Jul 30, 4:00 PM EDT
1 day
-2.01%
5 days
-6.71%
1 month
-4.49%
3 months
25.41%
6 months
164.98%
Year to date
210.96%
1 year
22.48%
5 years
-86.10%
10 years
-86.10%
 

About: 908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Employees: 246

0
Funds holding %
of 7,323 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

150% more capital invested

Capital invested by funds: $36.9M [Q4 2024] → $92.3M (+$55.4M) [Q1 2025]

100% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 2 (+1) [Q1 2025]

58% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 19

44% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 16

10.25% more ownership

Funds ownership: 48.12% [Q4 2024] → 58.37% (+10.25%) [Q1 2025]

7% more funds holding

Funds holding: 81 [Q4 2024] → 87 (+6) [Q1 2025]

31% less call options, than puts

Call options by funds: $336K | Put options by funds: $487K

Research analyst outlook

We haven’t received any recent analyst ratings for MASS.

Financial journalist opinion

Based on 3 articles about MASS published over the past 30 days

Neutral
Business Wire
1 day ago
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming Canaccord Genuity 45th Annual Growth Conference. 908 Devices' management is scheduled to present on Wednesday, August 13 at 1 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section.
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
Neutral
Business Wire
1 week ago
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today announced it will report financial results for the second quarter 2025 before market open on Tuesday, August 5, 2025. Company management will webcast a corresponding conference call beginning at 8:30 a.m. Eastern Time / 5:30 a.m. Pacific Time. Live audio of the webcast will be available o.
908 Devices to Report Second Quarter 2025 Financial Results on August 5, 2025
Neutral
Business Wire
3 weeks ago
908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances
BOSTON--(BUSINESS WIRE)-- #FTIR--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces the launch of VipIR, a 3-in-1 handheld analyzer that sets a new standard for rapid and confident field-based chemical identification of unknown bulk solids and liquids, such as narcotics, explosives, and toxic chemicals. VipIR enables customs and border personnel and hazardous response teams to simplify workflows and eliminate guesswork, accelerating decision ma.
908 Devices Launches VipIR, a 3-in-1 Handheld Analyzer for Field-Based Chemical Identification of Unknown Bulk Substances
Positive
Zacks Investment Research
1 month ago
908 Devices (MASS) Upgraded to Buy: Here's What You Should Know
908 Devices (MASS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
908 Devices (MASS) Upgraded to Buy: Here's What You Should Know
Neutral
Business Wire
1 month ago
Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500
NORRISTOWN, Pa.--(BUSINESS WIRE)--Asylon, the U.S. leader in robotic security solutions, in collaboration with 908 Devices, the Indianapolis Metropolitan Police Department, and the Indianapolis Motor Speedway, returned to this year's Indianapolis 500 to deploy its gas-sniffing security robots to help increase the safety and security of those attending the largest single-day sporting event in the world. More than 300,000 people attended this year's event, and Asylon's solution provided unprecede.
Asylon Robotics and 908 Devices Deliver Robotic Security at the 2025 Indianapolis 500
Neutral
Business Wire
1 month ago
908 Devices Appoints Christopher D. Brown to its Board of Directors
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that it has appointed Christopher D. Brown, PhD, Vice President, Analytics R&D at Repligen Corporation (Nasdaq: RGEN), and a 908 Devices Co-founder, to serve on its Board of Directors, effective immediately. Dr. Brown co-founded 908 Devices and served as the company's Chief Technology Officer & Vice President of Research & Development from February 2.
908 Devices Appoints Christopher D. Brown to its Board of Directors
Neutral
Business Wire
1 month ago
Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit
BOSTON--(BUSINESS WIRE)-- #chemID--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the Metropolitan Washington Council of Governments (COG) has purchased eight XplorIR devices, one for each of the seven counties and District of Columbia, which comprise the COG. The devices were shipped in Q1 2025, with training taking place in Q2 2025. The handheld XplorIR device accurately detects, identifies, and quantifies 5,000 unknown gas and vapor c.
Metropolitan Washington Council of Governments Adds 908 Devices' XplorIR to Its Hazardous Materials Response Toolkit
Positive
The Motley Fool
2 months ago
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
A deal agreed in a far-off country was the spark that ignited chemical analysis device maker 908 Devices (MASS -2.56%) this week. The company's stock burned hot, finishing the period over 18% higher in price, according to data compiled by S&P Global Market Intelligence.
Why 908 Devices Stock Rocketed More Than 18% Higher This Week
Positive
Zacks Investment Research
2 months ago
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
908 Devices (MASS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
All You Need to Know About 908 Devices (MASS) Rating Upgrade to Buy
Neutral
Business Wire
2 months ago
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
BOSTON--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, announced it will participate in the upcoming William Blair 45th Annual Growth Stock Conference. 908 Devices' management is scheduled to present on Wednesday, June 4 at 4 p.m. Central Time / 5 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on th.
908 Devices to Participate in the William Blair 45th Annual Growth Stock Conference
Charts implemented using Lightweight Charts™